ImmuPharma PLC (IMM) — Capital Reinvestment Ratio
Latest as of December 2009:
0.00x
ImmuPharma PLC (IMM) has a Capital Reinvestment Ratio of 0.00x as of December 2009, meaning it reinvests 0% of its operating cash flow (GBX11.96 Million) in capital expenditures (GBX3.60K). See cash generation quality of ImmuPharma PLC to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
GBX11.96 Million
GBX
Capital Expenditures
GBX3.60K
GBX
Data as of
Dec 2009
Most recent filing
ImmuPharma PLC Capital Reinvestment Ratio (2009–2009)
This chart tracks ImmuPharma PLC's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for ImmuPharma PLC (2009–2009)
Year-by-year Capital Reinvestment Ratio for ImmuPharma PLC from 2009 to 2009. For live market cap and broader valuation context, see ImmuPharma PLC stock valuation.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2009 | 0.00x | GBX11.96 Million | GBX4.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow